Skip to content

Clinical trials

Terminated Liver Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Status: Terminated Country / region: Canada Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20101
20121
20141
20161
20171
20181
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto2
Abbott1
Boehringer Ingelheim1
Bristol-Myers Squibb1
GlaxoSmithKline1
Johane Allard1
Mirum Pharmaceuticals, Inc.1
Ottawa Hospital Research Institute1
Target PharmaSolutions, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases10
Non-alcoholic Fatty Liver Disease3
Hepatitis B2
Liver Neoplasms2
Acquired Immunodeficiency Syndrome1
Adenocarcinoma1
Carcinoma1
Carcinoma, Hepatocellular1
Digestive System Diseases1
Digestive System Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.